Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies5,581–5,600 of 20,710
All studies
Polycystic ovary syndrome in type 1 diabetes mellitus: a cross-sectional study of 785 women with diabetes and 1152 controls
Interpretation of polycystic ovarian syndrome (PCOS) employing computational neural network CNN
Role of Gut Microbiota in Polycystic Ovary Syndrome
THE ASSOCIATION BETWEEN PREGESTATIONAL DIABETES IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ADVERSE OBSTETRIC OUTCOMES
P-616 Impact of Dehydroepiandrosterone sulfate and Free Androgen Index on pregnancy and neonatal outcomes in PCOS patients
All-trans retinoic acid and fibroblast growth factor-2 enhance the fertility rate and embryo development in polycystic ovary syndrome mouse model.
Nonhemodynamic Components of EVA: Polycystic Ovary Syndrome (PCOS)
Reply of the authors: Assessing the impact of PCOS on pregnancy complications in FET cycles: unexplored factors and clinical implications
Evaluation of Morphometric Parameters in PCOS Rats Treated with Standardized <i>Aronia melanocarpa L.</i> Extract and/or Metformin
A STUDY TO EVALUATE THE EFFECTIVENESS OF STRUCTURED TEACHING PROGRAMME IN KNOWLEDGE REGARDING POLYCYSTIC OVARIAN SYNDROME (PCOS) AMONG 1ST YEAR BSCNURSING STUDENT OF SMT. NAGARATHNAMMA COLLEGE OF NURSING, BENGALURU
The relationship between psychological distress and health related quality of life among women with Polycystic Ovary Syndrome
Polycystic ovary syndrome and metabolic syndrome: possible ways to correct metabolic disorders
Identification of mutations in the CYP19 gene in patients with polycystic ovary syndrome in Thi-Qar city
Clinical patterns and treatment outcomes of polycystic ovarian syndrome.
Exploring the Prevalence of PCOS: Addressing Challenges and Impact on Adolescent
PCOS – The Importance of Diet, Physical Activity, and Other Non-Pharmacological Methods in Treatment
The relevance of endocrine disruptors, obesity, and cytokines for polycystic ovary syndrome
Thyroid Disorders in Patients with Polycystic Ovarian Syndrome in a Tertiary Care Center: An Observational study.
Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS